世界のフルフェナジンデカノエート市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20DC11017)
◆英語タイトル:Global Fluphenazine Decanoate Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20DC11017
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年12月(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、フルフェナジンデカノエートの世界市場を広く調査・分析し、今後の市場展望をまとめております。フルフェナジンデカノエートの種類別市場規模(急性統合失調症、慢性統合失調症、その他)、用途別市場規模(子供、大人)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Atlantic Laboratories Corporation,Ltd.、WEST-WARD PHARMS INT、Shanghai Zhongxi Sunve Pharmaceutical、Southwest Pharmaceutical、MYLAN LABS LTD、Shanghai Harvest Pharmaceutical、PAR STERILE PRODUCTS、AUROBINDO PHARMA LTD、FRESENIUS KABI USA
・地域別グローバル市場分析 2015年-2020年
・フルフェナジンデカノエートの北米市場(アメリカ、カナダ、メキシコ)
・フルフェナジンデカノエートのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・フルフェナジンデカノエートのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・フルフェナジンデカノエートの南米市場(ブラジル、アルゼンチン)
・フルフェナジンデカノエートの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:急性統合失調症、慢性統合失調症、その他
・用途別分析:子供、大人
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Fluphenazine Decanoate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Fluphenazine Decanoate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Fluphenazine Decanoate market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Fluphenazine Decanoate market has been segmented into:
Acute Schizophrenia
Chronic Schizophrenia
Others

By Application, Fluphenazine Decanoate has been segmented into:
Children
Adult

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Fluphenazine Decanoate market presented in the report. This section sheds light on the sales growth of different regional and country-level Fluphenazine Decanoate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Fluphenazine Decanoate market.

The report offers in-depth assessment of the growth and other aspects of the Fluphenazine Decanoate market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Fluphenazine Decanoate Market Share Analysis
Fluphenazine Decanoate competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Fluphenazine Decanoate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Fluphenazine Decanoate sales, revenue and market share for each player covered in this report.

The major players covered in Fluphenazine Decanoate are:
Atlantic Laboratories Corporation,Ltd.
WEST-WARD PHARMS INT
Shanghai Zhongxi Sunve Pharmaceutical
Southwest Pharmaceutical
MYLAN LABS LTD
Shanghai Harvest Pharmaceutical
PAR STERILE PRODUCTS
AUROBINDO PHARMA LTD
FRESENIUS KABI USA
Among other players domestic and global, Fluphenazine Decanoate market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Fluphenazine Decanoate Market Overview
1.1 Product Overview and Scope of Fluphenazine Decanoate
1.2 Classification of Fluphenazine Decanoate by Type
1.2.1 Global Fluphenazine Decanoate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Fluphenazine Decanoate Revenue Market Share by Type in 2019
1.2.3 Acute Schizophrenia
1.2.4 Chronic Schizophrenia
1.2.5 Others
1.3 Global Fluphenazine Decanoate Market by Application
1.3.1 Overview: Global Fluphenazine Decanoate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Children
1.3.3 Adult
1.4 Global Fluphenazine Decanoate Market by Regions
1.4.1 Global Fluphenazine Decanoate Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Fluphenazine Decanoate (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Fluphenazine Decanoate Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Fluphenazine Decanoate Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Fluphenazine Decanoate Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Fluphenazine Decanoate Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Fluphenazine Decanoate Status and Prospect (2015-2025)
2 Company Profiles
2.1 Atlantic Laboratories Corporation,Ltd.
2.1.1 Atlantic Laboratories Corporation,Ltd. Details
2.1.2 Atlantic Laboratories Corporation,Ltd. Major Business
2.1.3 Atlantic Laboratories Corporation,Ltd. SWOT Analysis
2.1.4 Atlantic Laboratories Corporation,Ltd. Product and Services
2.1.5 Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.2 WEST-WARD PHARMS INT
2.2.1 WEST-WARD PHARMS INT Details
2.2.2 WEST-WARD PHARMS INT Major Business
2.2.3 WEST-WARD PHARMS INT SWOT Analysis
2.2.4 WEST-WARD PHARMS INT Product and Services
2.2.5 WEST-WARD PHARMS INT Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.3 Shanghai Zhongxi Sunve Pharmaceutical
2.3.1 Shanghai Zhongxi Sunve Pharmaceutical Details
2.3.2 Shanghai Zhongxi Sunve Pharmaceutical Major Business
2.3.3 Shanghai Zhongxi Sunve Pharmaceutical SWOT Analysis
2.3.4 Shanghai Zhongxi Sunve Pharmaceutical Product and Services
2.3.5 Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.4 Southwest Pharmaceutical
2.4.1 Southwest Pharmaceutical Details
2.4.2 Southwest Pharmaceutical Major Business
2.4.3 Southwest Pharmaceutical SWOT Analysis
2.4.4 Southwest Pharmaceutical Product and Services
2.4.5 Southwest Pharmaceutical Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.5 MYLAN LABS LTD
2.5.1 MYLAN LABS LTD Details
2.5.2 MYLAN LABS LTD Major Business
2.5.3 MYLAN LABS LTD SWOT Analysis
2.5.4 MYLAN LABS LTD Product and Services
2.5.5 MYLAN LABS LTD Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.6 Shanghai Harvest Pharmaceutical
2.6.1 Shanghai Harvest Pharmaceutical Details
2.6.2 Shanghai Harvest Pharmaceutical Major Business
2.6.3 Shanghai Harvest Pharmaceutical Product and Services
2.6.4 Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.7 PAR STERILE PRODUCTS
2.7.1 PAR STERILE PRODUCTS Details
2.7.2 PAR STERILE PRODUCTS Major Business
2.7.3 PAR STERILE PRODUCTS Product and Services
2.7.4 PAR STERILE PRODUCTS Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.8 AUROBINDO PHARMA LTD
2.8.1 AUROBINDO PHARMA LTD Details
2.8.2 AUROBINDO PHARMA LTD Major Business
2.8.3 AUROBINDO PHARMA LTD Product and Services
2.8.4 AUROBINDO PHARMA LTD Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
2.9 FRESENIUS KABI USA
2.9.1 FRESENIUS KABI USA Details
2.9.2 FRESENIUS KABI USA Major Business
2.9.3 FRESENIUS KABI USA Product and Services
2.9.4 FRESENIUS KABI USA Fluphenazine Decanoate Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Fluphenazine Decanoate Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Fluphenazine Decanoate Players Market Share
3.2.2 Top 10 Fluphenazine Decanoate Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Fluphenazine Decanoate Revenue and Market Share by Regions
4.2 North America Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
4.3 Europe Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
4.5 South America Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
5 North America Fluphenazine Decanoate Revenue by Countries
5.1 North America Fluphenazine Decanoate Revenue by Countries (2015-2020)
5.2 USA Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
5.3 Canada Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
5.4 Mexico Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
6 Europe Fluphenazine Decanoate Revenue by Countries
6.1 Europe Fluphenazine Decanoate Revenue by Countries (2015-2020)
6.2 Germany Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
6.3 UK Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
6.4 France Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
6.5 Russia Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
6.6 Italy Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Fluphenazine Decanoate Revenue by Countries
7.1 Asia-Pacific Fluphenazine Decanoate Revenue by Countries (2015-2020)
7.2 China Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
7.3 Japan Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
7.4 Korea Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
7.5 India Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
8 South America Fluphenazine Decanoate Revenue by Countries
8.1 South America Fluphenazine Decanoate Revenue by Countries (2015-2020)
8.2 Brazil Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
8.3 Argentina Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Fluphenazine Decanoate by Countries
9.1 Middle East & Africa Fluphenazine Decanoate Revenue by Countries (2015-2020)
9.2 Saudi Arabia Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
9.3 UAE Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
9.4 Egypt Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
9.5 South Africa Fluphenazine Decanoate Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Fluphenazine Decanoate Revenue and Market Share by Type (2015-2020)
10.2 Global Fluphenazine Decanoate Market Forecast by Type (2019-2024)
10.3 Acute Schizophrenia Revenue Growth Rate (2015-2025)
10.4 Chronic Schizophrenia Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Fluphenazine Decanoate Market Segment by Application
11.1 Global Fluphenazine Decanoate Revenue Market Share by Application (2015-2020)
11.2 Fluphenazine Decanoate Market Forecast by Application (2019-2024)
11.3 Children Revenue Growth (2015-2020)
11.4 Adult Revenue Growth (2015-2020)
12 Global Fluphenazine Decanoate Market Size Forecast (2021-2025)
12.1 Global Fluphenazine Decanoate Market Size Forecast (2021-2025)
12.2 Global Fluphenazine Decanoate Market Forecast by Regions (2021-2025)
12.3 North America Fluphenazine Decanoate Revenue Market Forecast (2021-2025)
12.4 Europe Fluphenazine Decanoate Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Fluphenazine Decanoate Revenue Market Forecast (2021-2025)
12.6 South America Fluphenazine Decanoate Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Fluphenazine Decanoate Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Atlantic Laboratories Corporation,Ltd.、WEST-WARD PHARMS INT、Shanghai Zhongxi Sunve Pharmaceutical、Southwest Pharmaceutical、MYLAN LABS LTD、Shanghai Harvest Pharmaceutical、PAR STERILE PRODUCTS、AUROBINDO PHARMA LTD、FRESENIUS KABI USA

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のフルフェナジンデカノエート市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Fluphenazine Decanoate Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。